TF and breast carcinoma: TF/FVIIa promotes p44/42 MAPK as well as Akt/protein kinase B phosphorylation in breast cancer cells, which in turn triggers the mTOR pathway that is involved in the regulation of several cancer-related processes such as cell survival, growth, proliferation, and motility [270].